• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Cervical cancer screening practices less cost-effective than suggested guidelines

byNicholas WoolfandSai Folmsbee
September 29, 2015
in Chronic Disease, Obstetrics, Oncology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. From a cost-effectiveness analysis, current screening practices failed to outperform every other screening scenario in terms of health benefits and costs.

2. The major factors associated with improvement were routine cytologic screening every 3 years and perfect compliance with referrals for colposcopy/biopsy.

Evidence Rating Level: 2 (Good)

Study Rundown: Cervical cancer causes death in over 4000 women per year in the United States, making it a significant public health concern. Although several screening and treatment strategies have helped reduce the number of women affected annually, the best implementation of these strategies is largely unknown. In the current study, a model-based cost-effectiveness analysis was conducted to compare the current screening practices in New Mexico to the recommended, guideline-based screening practices. The primary outcomes were health benefits (i.e. decrease in lifetime cervical cancer risk and increase in QALYs—quality-adjusted life years) and lifetime costs. From this, screening practices were inefficient compared to guideline-based practices. Contributors to inefficiency included variable screening frequency, inappropriate HPV triage testing and poor compliance with diagnostic and treatment referrals. The results suggest that health and monetary outcomes can be vastly improved by both implementing cytologic screening every 3 years for all eligible women and ensuring perfect compliance with diagnostic follow-up visits. While this study has potentially limited generalizability due to use of the New Mexico HPV Pap Registry (NMHPVPR) data from a short time period (2008-2011), its use of population-based screening data suggests achievable improvements to current U.S. cervical cancer screening practices.

Click to read the study published today in the Annals of Internal Medicine

Relevant Reading: American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

In-Depth [cost-effectiveness analysis]: The authors used data from the NMHPVPR to simulate current cervical cancer screening practices and compared them to recommended screening practices per USPSTF and ASCCP guidelines. These guidelines include cytology every 3 years for women aged 21-65 years and follow-up for diagnosis or treatment, if necessary. Based on the analysis, current screening practices reduced lifetime cancer incidence by 48.5% and mortality by 58.4% compared to no screening. Notably, guideline-based screening practices reduced incidence by 80.9% and mortality by 86.7%, both significantly greater than current practices. Improving current practices by adding both cytologic screening every 3 years and perfect compliance with diagnostic referral led to a 72.2% reduction in incidence and an 82.0% reduction in mortality. These changes were also financially sound, with incremental net monetary benefits of $753/QALY (when $50,000/QALY was the cutoff) and $1645/QALY (when $100,000/QALY was the cutoff).

RELATED REPORTS

Human papillomavirus (HPV) vaccination rates have increased in recent years

Human Papillomavirus self-sampling may be a culturally-sensitive alternative for Muslim women

COVID-19 pandemic associated with reductions in delivery of cancer care services in Ontario, Canada

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancer screeningcervical cancer
Previous Post

ACP releases practice guidelines for the evaluation of suspected acute pulmonary embolism

Next Post

2 Minute Medicine Rewind September 20 – September 27, 2015

RelatedReports

Mental health parity law associated with financial protection for children
Chronic Disease

Human papillomavirus (HPV) vaccination rates have increased in recent years

June 23, 2022
Reduced HPV vaccine doses may be adequate
Infectious Disease

Human Papillomavirus self-sampling may be a culturally-sensitive alternative for Muslim women

June 20, 2022
Chronic Disease

COVID-19 pandemic associated with reductions in delivery of cancer care services in Ontario, Canada

April 29, 2022
Cervical cancer screening practices less cost-effective than suggested guidelines
Oncology

Sintilimab plus anlotinib showed promising clinical and safety response to treat advanced cervical cancer

February 28, 2022
Next Post
Unmet healthcare need in adolescence linked to poor adult outcomes

2 Minute Medicine Rewind September 20 – September 27, 2015

Food environment associated with gestational diabetes

Behavioral programs for type 2 diabetes strengthened by delivery method and multifactorial content

Topical analgesia for dyspareunia effective in breast cancer survivors

Computer-aided detection not associated with improved accuracy in digital screening mammography

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.